Thursday , September 21 2017
Home / Tag Archives: Novo Nordisk

Tag Archives: Novo Nordisk

June, 2017

  • 1 June

    FDA Approves New Novo Nordisk Hemophilia B Treatment

    PLAINSBORO, N.J., May 31, 2017 /PRNewswire/ — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for REBINYN® (Coagulation Factor IX (Recombinant), GlycoPEGylated) for the treatment of adults and children with hemophilia B. Hemophilia B is a chronic and inherited bleeding …

November, 2016

  • 22 November

    Novo Nordisk’s Diabetes Drug Xultophy Wins FDA Approval

    PLAINSBORO, N.J., Nov. 21, 2016 /PRNewswire/ — Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application for Xultophy®100/3.6 (insulin degludec 100 units/mL and liraglutide 3.6 mg/mL injection). Xultophy® 100/3.6 is a once-daily, combination of Tresiba® (insulin degludec …

March, 2015